Cargando…
Changes in Class I and IIb HDACs by δ-Opioid in Chronic Rat Glaucoma Model
PURPOSE: This study determines if δ-opioid receptor agonist (i.e. SNC-121)-induced epigenetic changes via regulation of histone deacetylases (HDACs) for retinal ganglion cell (RGC) neuroprotection in glaucoma model. METHODS: Intraocular pressure was raised in rat eyes by injecting 2M hypertonic sali...
Autores principales: | Zaidi, Syed A. H., Guzman, Wendy, Singh, Sudha, Mehrotra, Shikhar, Husain, Shahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718808/ https://www.ncbi.nlm.nih.gov/pubmed/33263714 http://dx.doi.org/10.1167/iovs.61.14.4 |
Ejemplares similares
-
Reduction of Neuroinflammation by δ-Opioids Via STAT3-Dependent Pathway in Chronic Glaucoma Model
por: Husain, Shahid, et al.
Publicado: (2021) -
Histone Deacetylases Regulation by δ-Opioids in Human Optic Nerve Head Astrocytes
por: Zaidi, Syed A. H., et al.
Publicado: (2020) -
PI3K/Akt Pathway: A Role in δ-Opioid Receptor–Mediated RGC Neuroprotection
por: Husain, Shahid, et al.
Publicado: (2017) -
Regulation of Nitric Oxide Production by δ-Opioid Receptors during Glaucomatous Injury
por: Husain, Shahid, et al.
Publicado: (2014) -
Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9
por: Lenoir, Olivia, et al.
Publicado: (2011)